Evidence map›Paper›PMID 28428121›Full record

ReviewAutoimmunity reviews2017

The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface.

Ariel D Stock, Sivan Gelb, Ofer Pasternak, Ayal Ben-Zvi, Chaim Putterman

Abstract readReview
In one paragraph

Review in Autoimmunity reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations.Expert review of precision medicine and drug development · 2025
    Article
  13. Review
  14. Blood-Brain Barrier Disruption in Neuroimmunological Disease.International journal of molecular sciences · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ariel D StockDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave. F701, Bronx, NY 10461, United States.
Sivan GelbDepartment of Developmental Biology and Cancer Research, Faculty of Medicine, The Hebrew University, Jerusalem 91120, Israel.
Ofer PasternakDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, 1249 Boylston St., Boston, MA 02115, United States; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 1249 Boylston St., Boston, MA 02115, United States.
Ayal Ben-ZviDepartment of Developmental Biology and Cancer Research, Faculty of Medicine, The Hebrew University, Jerusalem 91120, Israel. Electronic address: ayalb@ekmd.huji.ac.il.
Chaim PuttermanDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave. F701, Bronx, NY 10461, United States; Division of Rheumatology, Albert Einstein College of Medicine, 1300 Morris Park Ave. F701, Bronx, NY 10461, United States. Electronic address: chaim.putterman@einstein.yu.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Training and DisseminationP41EB015902 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI KIKINIS, RON, WESTIN, CARL-FREDRIK · 2012 to 2022
$20.9M
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of NeuropsychiatricR01AR065594 · NIAMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PUTTERMAN, CHAIM · 2014 to 2018
$2.4M
Next Generation Diffusion MRI Biomarkers for Prodromal SchizophreniaR01MH108574 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI PASTERNAK, OFER · 2016 to 2020
$2.2M
NIAMS NIH HHS R01 AR065594NIBIB NIH HHS P41 EB015902NIGMS NIH HHS T32 GM007288NIMH NIH HHS R01 MH108574
6 · The paper itself

Abstract

Experts have previously postulated a linkage between lupus associated vascular pathology and abnormal brain barriers in the immunopathogenesis of neuropsychiatric lupus. Nevertheless, there are some discrepancies between the experimental evidence, or its interpretation, and the working hypotheses prevalent in this field; specifically, that a primary contributor to neuropsychiatric disease in lupus is permeabilization of the blood brain barrier. In this commonly held view, any contribution of the other known brain barriers, including the blood-cerebrospinal fluid and meningeal barriers, is mostly excluded from the discussion. In this review we will shed light on some of the blood brain barrier hypotheses and try to trace their roots. In addition, we will suggest new research directions to allow for confirmation of alternative interpretations of the experimental evidence linking the pathology of intra-cerebral vasculature to the pathogenesis of neuropsychiatric lupus.

Indexed as

AnimalsBlood-Brain BarrierHumansLupus Vasculitis, Central Nervous SystemBlood-brain-barrierBlood-CSF barrierChoroid plexusGlymphaticsNeuropsychiatric lupusSLE

Identifiers

PMID28428121
PMCPMC6068398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.